Back
Speaker illustration

Doctor Dimitrios Moysidis

University Hospital Zurich, Zurich (Switzerland)

Dr. Dimitrios Moysidis is a Cardiology Resident and PhD Candidate at Aristotle University of Thessaloniki (AUTH), focusing his research on coronary artery disease, atherosclerosis, and advanced imaging techniques. Since June 2024, Dr. Moysidis has also been a Research Associate at the University Hospital Zürich (USZ) in the Coronary Atherosclerosis Laboratory within the Cardiovascular Imaging Division, where he actively engages in research utilizing coronary CT angiography (CCTA) and computational fluid dynamics (CFD) to study coronary atherosclerosis. Dr. Moysidis has coordinated and contributed to several large-scale clinical studies and has published over 100 peer-reviewed articles. Fluent in English, German, and Greek, he combines his professional dedication with personal interests, including hiking, traveling, and historical literature, aligning his passions with a commitment to advancing global healthcare and medical innovation.

Presentations Articles

Rationale and development of the computed tomography simulated pressure loss index (CTSPLI) for non-invasive phenotyping of coronary atherosclerosis

Event: EACVI 2025

Topic: Imaging of Coronary Artery Disease

Session: From atherosclerosis to myocardial infarction: how to image each stage?

Access
Like
Thumbnail

Association of coronary artery disease phenotypes with myocardial perfusion defects and impaired myocardial blood flow - A hybrid CCTA-CTFFR and 13N-NH3 PET/CT study

Event: EACVI 2025

Topic: Imaging of Coronary Artery Disease

Session: From atherosclerosis to myocardial infarction: how to image each stage?

Access
Like
Thumbnail

Acute myocardial infarction in patients without standard modifiable risk factors - preliminary data on clinical and laboratory biomarkers from the beyond-smurfs study

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Risk stratification in acute coronary syndromes (3)

Access
Like
Thumbnail

Prescription rates of guideline-directed medical treatment across the eGFR continuum in patients with heart failure: Insights from the MISOAC-AF trial

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 9

Access
Like
Thumbnail

Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum

Event: Heart Failure 2021

Topic: Heart Failure in Atrial Fibrillation

Session: ePoster session

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources